Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials
Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Methods Forty patients receiving 5 x 5 Gy in a phase II...
Saved in:
Published in: | Radiation oncology (London, England) Vol. 16; no. 1 |
---|---|
Main Authors: | , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
BioMed Central Ltd
07-01-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Methods Forty patients receiving 5 x 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 x 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). Results After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 x 5 Gy and 87% after 10 x 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 x 5 Gy and 85% after 10 x 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). Conclusions 5 x 5 Gy in 1 week appeared similarly effective as 10 x 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 x 5 Gy and 10 x 3 Gy. Trial registration clinicaltrials.gov NCT03070431. Registered 27 February 2017. Keywords: Metastatic spinal cord compression, Radiotherapy alone, Local progression-free survival, Motor function, Ambulatory status, Overall survival |
---|---|
AbstractList | In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Forty patients receiving 5 x 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 x 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 x 5 Gy and 87% after 10 x 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 x 5 Gy and 85% after 10 x 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). 5 x 5 Gy in 1 week appeared similarly effective as 10 x 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 x 5 Gy and 10 x 3 Gy. Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Methods Forty patients receiving 5 x 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 x 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). Results After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 x 5 Gy and 87% after 10 x 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 x 5 Gy and 85% after 10 x 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). Conclusions 5 x 5 Gy in 1 week appeared similarly effective as 10 x 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 x 5 Gy and 10 x 3 Gy. Trial registration clinicaltrials.gov NCT03070431. Registered 27 February 2017. Keywords: Metastatic spinal cord compression, Radiotherapy alone, Local progression-free survival, Motor function, Ambulatory status, Overall survival |
Audience | Academic |
Author | Schild, Steven E Conde-Moreno, Antonio J Lomidze, Darejan Hollaender, Niels H Rades, Dirk Cacicedo, Jon Segedin, Barbara Ciervide, Raquel |
Author_xml | – sequence: 1 fullname: Rades, Dirk – sequence: 2 fullname: Cacicedo, Jon – sequence: 3 fullname: Conde-Moreno, Antonio J – sequence: 4 fullname: Segedin, Barbara – sequence: 5 fullname: Lomidze, Darejan – sequence: 6 fullname: Ciervide, Raquel – sequence: 7 fullname: Hollaender, Niels H – sequence: 8 fullname: Schild, Steven E |
BookMark | eNptUE1LQzEQDFLBtvoHPAU8p-bzpTmWolUoeOnBW8nLR430JY8kiv57U_TQgyw7s7PMzmFnYBJTdADcErwgZNndF8Iw4QhTjDCRTCJ5AaZE8iWSRL5OzuYrMCvlHWMuGFZTUNdpGHUOJUWYPBTwq_XmG-poIcFNsZPyKcPBVV2qrsHAMoaoj9CkbBsMY3alhBbwUUI8QKurhj6nAda37BwccyqjMzV8Olhz0MdyDS59I3fzx3Owe3zYrZ_Q9mXzvF5t0YEIWhG1sidMdpQojXnfO87UCSzXnGKpuBKUWCV65blYOsp4L4kwxlnFWK_YHNz9xh700e1D9KlmbYZQzH7VCSxUp4RorsU_rlbWDcG0N_vQ9mcHPy7wbdg |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. |
DOI | 10.1186/s13014-020-01737-7 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1748-717X |
ExternalDocumentID | A650596955 |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- -A0 0R~ 123 29P 2WC 3V. 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFS ACRMQ ADBBV ADINQ ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ HMCUK HYE I-F IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ TUS UKHRP WOQ WOW ~8M |
ID | FETCH-LOGICAL-g152t-2d7b1376219a04bbe439be43d4a4207949521d95b9f458e234b715cced933b93 |
ISSN | 1748-717X |
IngestDate | Tue Nov 19 20:41:24 EST 2024 Tue Nov 12 22:50:58 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-g152t-2d7b1376219a04bbe439be43d4a4207949521d95b9f458e234b715cced933b93 |
ParticipantIDs | gale_infotracmisc_A650596955 gale_infotracacademiconefile_A650596955 |
PublicationCentury | 2000 |
PublicationDate | 20210107 |
PublicationDateYYYYMMDD | 2021-01-07 |
PublicationDate_xml | – month: 01 year: 2021 text: 20210107 day: 07 |
PublicationDecade | 2020 |
PublicationTitle | Radiation oncology (London, England) |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd |
Publisher_xml | – name: BioMed Central Ltd |
SSID | ssj0045309 |
Score | 2.3418832 |
Snippet | Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible.... In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study... |
SourceID | gale |
SourceType | Aggregation Database |
SubjectTerms | Care and treatment Complications and side effects Development and progression Dose-response relationship (Biochemistry) Metastasis Spinal cord compression |
Title | Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLamRUJcKsoiulD5gMQhsshiZzmWYWgv5QBzqLhUSexUHEjQLFL59_2encXQguiBQ6yxM_GM8j69zW9h7I0qlG7SMBcmk9TCLDcil1KKFMqrpopVse2icP4l-3SZf1jIxWw29Eub1v4rpbEGWlPm7AOoPW6KBXwGzTGC6hj_ie5zv7FgoIIbXGeuyFIUYpbQjGILv5tNSelE3-pg_cP2xiJD1MaYu9jYNthaRwIFkQ5pKCtDiVXdkJ8Z2KYfa1_D_UzFDpwa2tauwNN9XUM8DwSecLwK7HfMG5qXNViY7noP_7iMfYy46Fam7fraB2BKnXe4Za5JHHtHKb5fI46sXyP7g4_bi3EiLp3JXMAOvXRC7J61gbWnv0P4rsSwB1jriExLQbY0WFSSiWySj2PU4im0WVWkhVI77FEMxmbzBd9_HSS_VIkNKRr_ypCklafv7v5ArwN42szyKdvrzRB-6vCzz2amfcYeX_SBFs_ZZoIR7xqu-A2us58clONRiFlCM8CITzDiDkacYMQ9GHELI04w4gQjbmHEPRhxB6MXbPlxsZyfi75Bh7iG2rcRsc6qCBIKUq8MZVUZaLc0aFnKOASnL6Ac6kJVRSNVbuJEVlmkaqAH764qkpdst-1a84pxqU1cwLRODDZKTFU2eZjEVaO0URRqcMDe0su6ItIBD3XZJ4_gaapfdjWR5oAd__JNcMvau33499tH7MmExWO2u1ltzWu2s9bbE-utObEEvwXb5YCS |
link.rule.ids | 315,782,786,866,27933,27934 |
linkProvider | BioMedCentral |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+5+x+5+Gy+and+10+x+3+Gy+for+metastatic+spinal+cord+compression+using+data+from+three+prospective+trials&rft.jtitle=Radiation+oncology+%28London%2C+England%29&rft.au=Rades%2C+Dirk&rft.au=Cacicedo%2C+Jon&rft.au=Conde-Moreno%2C+Antonio+J&rft.au=Segedin%2C+Barbara&rft.date=2021-01-07&rft.pub=BioMed+Central+Ltd&rft.issn=1748-717X&rft.eissn=1748-717X&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs13014-020-01737-7&rft.externalDocID=A650596955 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1748-717X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1748-717X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1748-717X&client=summon |